The pooled OR was 2.82 (95% CI: 1.84-4.33, p < 0.001) with significant heterogeneity (I2 = 72.2%, p < 0.001), demonstrating that patients with up-regulated TUG1 expression are more likely to develop higher tumor stage. Here, TUG1 is linked to neoplasm.